 |
| Image: contractsandagreements.co.uk |
And there was me thinking it was just patients/consumers who were suing Glaxo over their Achilles Heel, Paxil?
Apparently not.
Bloomberg are reporting that Mylan Inc, a global generic and specialty pharmaceuticals company, have sued U.K. drugmaker GlaxoSmithKline Plc and Apotex Inc. to stop them from selling the antidepressant Paxil CR as a generic drug, claiming the sales violate an exclusive licensing contract.
Apparently Glaxo have broke thier original contract with Mylan by allowing Apotex to sell Paxil without the label, under the chemical name paroxetine hydrochloride.
They had originally given exclusivity to Mylan.
Unlike Glaxo to be involved in such shenanigans, isn't it?
Hat-Tip: Cyndi White
FULL STORY
Fid
ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING
No comments: